We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rectal Probe Helps Visualize Prostate Elasticity

By HospiMedica International staff writers
Posted on 23 May 2012
An innovative rectal probe employs mechanical sensors that detect the stiffness of the prostate while it is being palpated. More...


The ProUroScan prostate mechanical imaging (PMI) system provides an image of the pressures that are generated from palpation of the posterior surface of the prostate, by creating a stress pattern when a rectal probe is pressed against the prostate through the rectal wall. Temporal and spatial changes in the stress pattern provide information on the elastic structure of the gland, and allow two-dimensional reconstruction of prostate anatomy and visualization of prostate mechanical properties. The image is displayed on a screen that allows physicians to visualize tissue abnormalities in the prostate gland, and the results can be stored electronically as a digital record.

The ProUroScan System probe is specially designed for the rectal anatomy, minimizing patient discomfort. A unique positioning system ensures that the person administering the scan examines the entire surface of the prostate, and assists prostate image construction. When the results are consistent with a digital rectal exam (DRE) finding, they can be permanently stored in electronic medical records (EMRs) for future analysis and comparison. The ProUroScan device is a product of ProUroCare Medical (Eden Prairie, MN, USA), and has been approved by the US Food and Drug Administration (FDA).

“A color image can go a long way in documenting a person's prostate condition, and this development puts us one step closer to supplementing other screening measures with a helpful, high quality visual aid that can be referred and compared to over time,” said Rick Carlson, CEO of ProUroCare Medical.

“Having a visual aid of irregularities can be so helpful to physicians and patients, particularly in the area of prostate care where decision-making is often difficult,” added Robert Weiss, MD, a urologic oncologist with the Cancer Institute of New Jersey (New Brunswick, USA). “The quality and resolution of the images are excellent, providing an immensely valuable supplement to the DRE, where physicians must rely on a gloved finger to feel for changes in the size and shape of the gland.”

Related Links:

ProUroCare Medical
Cancer Institute of New Jersey



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.